Copyright Reports & Markets. All rights reserved.

Global Respiratory Distress Syndrome Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Poractant Alfa
      • 1.4.3 Beractant
      • 1.4.4 Calfactant
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Respiratory Distress Syndrome Market Share by Application (2019-2025)
      • 1.5.2 Very Preterm Infants
      • 1.5.3 Moderate to Late Preterm Infants
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Respiratory Distress Syndrome Market Size
    • 2.2 Respiratory Distress Syndrome Growth Trends by Regions
      • 2.2.1 Respiratory Distress Syndrome Market Size by Regions (2019-2025)
      • 2.2.2 Respiratory Distress Syndrome Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Respiratory Distress Syndrome Market Size by by Players
      • 3.1.1 Global Respiratory Distress Syndrome Revenue by by Players (2014-2019)
      • 3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI)
    • 3.2 Respiratory Distress Syndrome Key Players Head office and Area Served
    • 3.3 Key Players Respiratory Distress Syndrome Product/Solution/Service
    • 3.4 Date of Enter into Respiratory Distress Syndrome Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Respiratory Distress Syndrome Market Size by Type (2014-2019)
    • 4.2 Global Respiratory Distress Syndrome Market Size by Application (2014-2019)

    5 Europe

    • 5.1 Europe Respiratory Distress Syndrome Market Size (2014-2019)
    • 5.2 Respiratory Distress Syndrome Key Players in Europe
    • 5.3 Europe Respiratory Distress Syndrome Market Size by Type
    • 5.4 Europe Respiratory Distress Syndrome Market Size by Application

    6 China

    • 6.1 China Respiratory Distress Syndrome Market Size (2014-2019)
    • 6.2 Respiratory Distress Syndrome Key Players in China
    • 6.3 China Respiratory Distress Syndrome Market Size by Type
    • 6.4 China Respiratory Distress Syndrome Market Size by Application

    7 Iran

    • 7.1 Iran Respiratory Distress Syndrome Market Size (2014-2019)
    • 7.2 Respiratory Distress Syndrome Key Players in Iran
    • 7.3 Iran Respiratory Distress Syndrome Market Size by Type
    • 7.4 Iran Respiratory Distress Syndrome Market Size by Application

    8 United States

    • 8.1 United States Respiratory Distress Syndrome Market Size (2014-2019)
    • 8.2 Respiratory Distress Syndrome Key Players in United States
    • 8.3 United States Respiratory Distress Syndrome Market Size by Type
    • 8.4 United States Respiratory Distress Syndrome Market Size by Application

    9 Korea

    • 9.1 Korea Respiratory Distress Syndrome Market Size (2014-2019)
    • 9.2 Respiratory Distress Syndrome Key Players in Korea
    • 9.3 Korea Respiratory Distress Syndrome Market Size by Type
    • 9.4 Korea Respiratory Distress Syndrome Market Size by Application

    10 International Players Profiles

    • 10.1 Chiesi Farmaceutici
      • 10.1.1 Chiesi Farmaceutici Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Respiratory Distress Syndrome Introduction
      • 10.1.4 Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2014-2019))
      • 10.1.5 Chiesi Farmaceutici Recent Development
    • 10.2 CR-Double Crane
      • 10.2.1 CR-Double Crane Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Respiratory Distress Syndrome Introduction
      • 10.2.4 CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2014-2019)
      • 10.2.5 CR-Double Crane Recent Development
    • 10.3 ONY Biotech
      • 10.3.1 ONY Biotech Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Respiratory Distress Syndrome Introduction
      • 10.3.4 ONY Biotech Revenue in Respiratory Distress Syndrome Business (2014-2019)
      • 10.3.5 ONY Biotech Recent Development
    • 10.4 AbbVie
      • 10.4.1 AbbVie Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Respiratory Distress Syndrome Introduction
      • 10.4.4 AbbVie Revenue in Respiratory Distress Syndrome Business (2014-2019)
      • 10.4.5 AbbVie Recent Development
    • 10.5 Yuhan Corporation
      • 10.5.1 Yuhan Corporation Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Respiratory Distress Syndrome Introduction
      • 10.5.4 Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2014-2019)
      • 10.5.5 Yuhan Corporation Recent Development
    • 10.6 JW Pharmaceuticals
      • 10.6.1 JW Pharmaceuticals Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Respiratory Distress Syndrome Introduction
      • 10.6.4 JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2014-2019)
      • 10.6.5 JW Pharmaceuticals Recent Development
    • 10.7 Noargen
      • 10.7.1 Noargen Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Respiratory Distress Syndrome Introduction
      • 10.7.4 Noargen Revenue in Respiratory Distress Syndrome Business (2014-2019)
      • 10.7.5 Noargen Recent Development
    • 10.8 Market Breakdown by Regions
      • 10.8.1 Market Breakdown by Regions Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Respiratory Distress Syndrome Introduction
      • 10.8.4 Market Breakdown by Regions Revenue in Respiratory Distress Syndrome Business (2014-2019)
      • 10.8.5 Market Breakdown by Regions Recent Development
    • 10.9 North America
      • 10.9.1 North America Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Respiratory Distress Syndrome Introduction
      • 10.9.4 North America Revenue in Respiratory Distress Syndrome Business (2014-2019)
      • 10.9.5 North America Recent Development
    • 10.10 Europe
      • 10.10.1 Europe Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Respiratory Distress Syndrome Introduction
      • 10.10.4 Europe Revenue in Respiratory Distress Syndrome Business (2014-2019)
      • 10.10.5 Europe Recent Development
    • 10.11 China
    • 10.12 Korea
    • 10.13 RoW

    11 Market Forecast 2019-2025

    • 11.1 Market Size Forecast by Product (2019-2025)
    • 11.2 Market Size Forecast by Application (2019-2025)
    • 11.3 Market Size Forecast by Regions
    • 11.4 Europe
    • 11.5 China
    • 11.6 Iran
    • 11.7 United States
    • 11.8 Korea

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Disclaimer

      This report focuses on the global Respiratory Distress Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Respiratory Distress Syndrome development in Europe, China, Iran, United States and Korea.

      The key players covered in this study
      Chiesi Farmaceutici
      CR-Double Crane
      ONY Biotech
      AbbVie
      Yuhan Corporation
      JW Pharmaceuticals
      Noargen
      Market Breakdown by Regions
      North America
      Europe
      China
      Korea
      RoW

      Market segment by Type, the product can be split into
      Poractant Alfa
      Beractant
      Calfactant
      Others

      Poractant Alpha's largest market share is broken down to 67%.

      Market segment by Application, split into
      Very Preterm Infants
      Moderate to Late Preterm Infants
      Others

      Very Preterm shapes the largest segment of the application market

      Market segment by Regions/Countries, this report covers
      Europe
      China
      Iran
      United States
      Korea

      The study objectives of this report are:
      To analyze global Respiratory Distress Syndrome status, future forecast, growth opportunity, key market and key players.
      To present the Respiratory Distress Syndrome development in Europe, China, Iran, United States and Korea.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Respiratory Distress Syndrome are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now